Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARTISTEM vs Debridement in Knee Cartilage Lesions and Osteoarthritis
NCT07339111Phase 3Recruiting
- Start
- Mar 2026
- Primary completion
- Jun 2029
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Cartistem in knee articular cartilage defect, osteoarthritis (OA). Started Mar 2026; status: recruiting.
02
Drugs
Cartistem
03
Conditions
knee articular cartilage defectosteoarthritis (OA)
Beyond the preview
Go deeper on NCT07339111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07339111.